Research graph
References from Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations. Local targets link to admitted publications; unresolved targets remain external evidence.
Right drug-right patient-right time: personalized medicine coalition
10.1111/j.1752-8062.2008.00003.x · 2008 · External reference
Towards precision medicine in the clinic: from biomarker discovery to novel therapeutics
10.1016/j.tips.2016.10.012 · 2016 · External reference
Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine
10.1016/j.coph.2008.07.007 · 2008 · External reference
The evidence framework for precision cancer medicine
10.1038/nrclinonc.2017.186 · 2017 · External reference
Precision medicine–personalized, problematic, and promising
10.1056/nejmsb1503104 · 2015 · External reference
10.3390/molecules24010049
10.3390/molecules24010049 · External reference
10.1038/nrd.2017.226
10.1038/nrd.2017.226 · External reference
Targeted radionuclide therapy: an evolution toward precision cancer treatment
10.2214/ajr.17.18264 · 2017 · External reference
10.3390/proteomes4040029
10.3390/proteomes4040029 · External reference
10.1124/pr.117.015388
10.1124/pr.117.015388 · External reference
10.3390/ijms21051682
10.3390/ijms21051682 · External reference
Analysis tool web services from the EMBL-EBI
10.1093/nar/gkt376 · 2013 · External reference
Comprehensive assessment of somatostatin receptors in various neoplasms: a systematic review
10.3390/pharmaceutics14071394 · 2022 · External reference
Somatostatin and the somatostatin receptors: versatile regulators of biological activity
2006 · External reference
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer
10.1002/pros.23426 · 2017 · External reference
10.1006/bbrc.1999.0699
10.1006/bbrc.1999.0699 · External reference
Pasireotide (SOM230): development, mechanism of action and potential applications
10.1016/j.mce.2007.09.006 · 2008 · External reference
10.3390/molecules25174012
10.3390/molecules25174012 · External reference
Correlation and comparison of somatostatin receptor type 2 immunohistochemical scoring systems with 68Ga-DOTATATE positron emission tomography/computed tomography imaging in gastroenteropancreatic neuroendocrine neoplasms
10.1159/000517530 · 2022 · External reference
Unresolved reference
2022 · External reference
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas
10.1159/000167796 · 2009 · External reference
δ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling
10.1371/journal.pone.0085193 · 2014 · External reference
Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models
10.1016/j.ejphar.2006.03.082 · 2006 · External reference
Somatostatin receptor SSTR2A AND SSTR5 expression in neuroendocrine breast cancer
10.1016/j.anndiagpath.2018.11.002 · 2019 · External reference
Regulation of endogenous (male) rodent GLP-1 secretion and human islet insulin secretion by antagonism of somatostatin receptor 5
10.1210/en.2017-00639 · 2017 · External reference
The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells
2012 · External reference
Efficacy of the new long-acting formulation of lanreotide (lanreotide autogel) in the management of acromegaly
10.1210/jcem.87.1.8153 · 2002 · External reference
Pasireotide—a novel somatostatin receptor ligand after 20 years of use
10.1007/s11154-022-09710-3 · 2022 · External reference
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers
2022 · External reference
10.1038/s41422-022-00679-x
10.1038/s41422-022-00679-x · External reference
Interaction of radiopharmaceuticals with somatostatin receptor 2 revealed by molecular dynamics simulations
10.1021/acs.jcim.3c00712 · 2023 · External reference
10.1038/s41594-022-00727-5
10.1038/s41594-022-00727-5 · External reference
Theoretical analysis of somatostatin receptor 5 with antagonists and agonists for the treatment of neuroendocrine tumors
10.1007/s11030-016-9722-7 · 2017 · External reference
10.1021/acsomega.0c02847
10.1021/acsomega.0c02847 · External reference
10.1002/prot.26267
10.1002/prot.26267 · External reference
Computer modelling of all types of somatostatin receptors
2020 · External reference
10.3390/ijms23136878
10.3390/ijms23136878 · External reference
10.1038/s41594-022-00859-8
10.1038/s41594-022-00859-8 · External reference
Molecular simulations of SSTR2 dynamics and interaction with ligands
10.1038/s41598-023-31823-1 · 2023 · External reference
10.1038/s41401-022-00938-y
10.1038/s41401-022-00938-y · External reference
Unresolved reference
1995 · External reference
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design
10.1038/s41467-021-25020-9 · 2021 · External reference
10.7554/elife.50279
10.7554/elife.50279 · External reference
10.1038/s41594-021-00674-7
10.1038/s41594-021-00674-7 · External reference
10.1146/annurev-biochem-060614-033910
10.1146/annurev-biochem-060614-033910 · External reference
10.1021/acs.chemrev.6b00177
10.1021/acs.chemrev.6b00177 · External reference
10.1111/j.1476-5381.2011.01629.x
10.1111/j.1476-5381.2011.01629.x · External reference
10.1021/acs.jcim.1c01056
10.1021/acs.jcim.1c01056 · External reference
10.1016/j.mce.2016.11.023
10.1016/j.mce.2016.11.023 · External reference
ProLIF: a library to encode molecular interactions as fingerprints
10.1186/s13321-021-00548-6 · 2021 · External reference
10.1016/s0005-2736(03)00235-9
10.1016/s0005-2736(03)00235-9 · External reference
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine
10.1038/s41467-023-36673-z · 2023 · External reference
10.1038/s41422-022-00669-z
10.1038/s41422-022-00669-z · External reference
Cryo-EM structure of the human somatostatin receptor 2 complex with its agonist somatostatin delineates the ligand-binding specificity
2022 · External reference
Structural insights into the activation of somatostatin receptor 2 by cyclic SST analogues
10.1038/s41421-022-00405-2 · 2022 · External reference
10.1038/s41589-022-01130-3
10.1038/s41589-022-01130-3 · External reference
The protein data bank
10.1093/nar/28.1.235 · 2000 · External reference
Comparative protein structure modeling using modeller
2006 · External reference
The VEGA suite of programs: an versatile platform for cheminformatics and drug design projects
10.1093/bioinformatics/btaa774 · 2021 · External reference
10.1038/s41586-021-03819-2
10.1038/s41586-021-03819-2 · External reference
10.1093/nar/gkac1013
10.1093/nar/gkac1013 · External reference
10.1002/pro.5560020916
10.1002/pro.5560020916 · External reference
MolProbity: more and better reference data for improved all-atom structure validation
10.1002/pro.3330 · 2018 · External reference
The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes
10.1016/j.jmb.2015.09.014 · 2016 · External reference
Cyclization and docking protocol for cyclic peptide–protein modeling using HADDOCK2.4
10.1021/acs.jctc.2c00075 · 2022 · External reference
10.1002/pro.3280
10.1002/pro.3280 · External reference
10.1002/jcc.20945
10.1002/jcc.20945 · External reference
Role of lipid composition on the structural and mechanical features of axonal membranes: a molecular simulation study
10.1038/s41598-019-44318-9 · 2019 · External reference
10.1021/jz501780a
10.1021/jz501780a · External reference
ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution
10.1021/acs.jctc.9b00591 · 2019 · External reference
Lipid21: complex lipid membrane simulations with AMBER
10.1021/acs.jctc.1c01217 · 2022 · External reference
An overview of the AMBER biomolecular simulation package
10.1002/wcms.1121 · 2013 · External reference
A fast shake algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations
10.1002/1096-987x(20010415)22:5<501::aid-jcc1021>3.0.co;2-v · 2001 · External reference
10.1063/1.464397
10.1063/1.464397 · External reference
Optimized hydrogen mass repartitioning scheme combined with accurate temperature/pressure evaluations for thermodynamic and kinetic properties of biological systems
10.1021/acs.jctc.1c00185 · 2021 · External reference
10.1021/ct400341p
10.1021/ct400341p · External reference
10.1021/ct700119m
10.1021/ct700119m · External reference
